LivaNova PLC Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by LivaNova PLC on September 15, 2022. The report discloses a corporate governance event regarding the appointment of a new member to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the appointment of Brooke Story to the Board of Directors, effective September 15, 2022. Ms. Story brings over 20 years of experience in the global medical technology industry, including roles at BD, Medtronic, and Johnson & Johnson.
Compensation and Governance Details
Consistent with the Company's Remuneration Policy, Ms. Story's compensation package includes:
- A prorated annual board retainer fee of $110,000.
- A prorated annual member fee of $8,000 for the Nominating and Corporate Governance Committee.
- An annual, service-based restricted stock award grant with a fair market value of $130,000, prorated.
The filing confirms no undisclosed arrangements or understandings regarding her selection and states she has not participated in any transactions requiring disclosure under Item 404(a) of Regulation S-K since January 1, 2021.
Investor Verification Checklist
- Verify the effective date of Brooke Story's board appointment (September 15, 2022).
- Confirm the total value of the initial compensation package ($110,000 retainer + $8,000 committee fee + $130,000 stock award).
- Review the Company's full Remuneration Policy to understand the standard compensation structure for non-employee directors.
- Check subsequent filings for any updates to the Board composition or additional director appointments.